SCHEMBL22015496

SCHEMBL22015496

Cc1cn2ccc3ccccc3c2nc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
MAPT P10636 6/20 0.49
RAB9A P51151 6/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 4/20 0.49
NPC1 O15118 4/20 0.49
TP53 P04637 3/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
KMT2A Q03164 1/20 0.49
RELA Q04206 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
BLM P54132 1/20 0.48
IDO1 P14902 1/20 0.39
PARP1 P09874 1/20 0.38
MAPK1 P28482 2/20 0.38
HCRTR1 O43613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3256643 0.80 ALDH1A1 (0.54) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL1384232 0.76 MAPT (0.53) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL8182696 0.75 ALDH1A1 (0.57) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL11664265 0.74 ALDH1A1 (0.46) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL14360013 0.73 MAPT (0.53) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL13325835 0.72 ALDH1A1 (0.72) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL9807923 0.71 MAPT (0.41) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL14474713 0.71 MAPT (0.43) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL11419932 0.70 ALDH1A1 (0.71) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL10028046 0.70 MAPT (0.51) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468972-B1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2020-05-20 EP disclosed